IRIS
GNECCHI, MASSIMILIANO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.090
EU - Europa 2.224
AS - Asia 1.616
SA - Sud America 16
AF - Africa 11
Continente sconosciuto - Info sul continente non disponibili 7
OC - Oceania 6
Totale 6.970
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.054
CN - Cina 1.339
IE - Irlanda 814
IT - Italia 387
FI - Finlandia 323
UA - Ucraina 230
DE - Germania 211
SG - Singapore 191
SE - Svezia 108
GB - Regno Unito 46
FR - Francia 37
CA - Canada 34
BE - Belgio 32
JP - Giappone 22
IN - India 20
BR - Brasile 13
NL - Olanda 11
MU - Mauritius 9
AU - Australia 6
ID - Indonesia 6
MY - Malesia 6
CZ - Repubblica Ceca 5
EU - Europa 5
IR - Iran 5
KR - Corea 5
RU - Federazione Russa 5
PK - Pakistan 4
TR - Turchia 4
HK - Hong Kong 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AT - Austria 2
ES - Italia 2
IQ - Iraq 2
LT - Lituania 2
MK - Macedonia 2
PE - Perù 2
TW - Taiwan 2
VN - Vietnam 2
ZA - Sudafrica 2
CH - Svizzera 1
EC - Ecuador 1
EE - Estonia 1
GR - Grecia 1
JO - Giordania 1
LA - Repubblica Popolare Democratica del Laos 1
MD - Moldavia 1
MN - Mongolia 1
MX - Messico 1
OM - Oman 1
PA - Panama 1
PL - Polonia 1
PT - Portogallo 1
RO - Romania 1
SA - Arabia Saudita 1
Totale 6.970
Salva come PNG Salva come JPEG
Città #
Dublin 814
Chandler 686
Nanjing 363
Jacksonville 318
Ashburn 208
Boardman 197
Beijing 177
Helsinki 156
Wilmington 146
Princeton 145
Singapore 136
Lawrence 134
Nanchang 131
New York 126
Hebei 103
Shenyang 94
Changsha 93
Medford 92
Jiaxing 86
Pavia 83
Shanghai 78
Ann Arbor 76
Hangzhou 64
Tianjin 42
Milan 40
Woodbridge 28
Brussels 27
Toronto 27
Norwalk 23
Dearborn 22
Falls Church 22
Los Angeles 21
Fairfield 19
Seattle 18
Tokyo 16
Verona 14
Washington 13
Piscataway 12
Rome 12
Chieti 10
Redwood City 10
Zhengzhou 10
Guangzhou 8
Catanzaro 7
Des Moines 7
Falkenstein 7
Forlì 7
Kunming 7
Pescara 7
Dallas 6
Jakarta 6
Jinan 6
Munich 6
Palermo 6
Pune 6
Utrecht 6
Bologna 5
Taizhou 5
Brno 4
Frankfurt am Main 4
Hefei 4
Lahore 4
Las Vegas 4
Leuven 4
Mountain View 4
Ningbo 4
Ottawa 4
Seri Kembangan 4
Berlin 3
Ferrara 3
Guardiagrele 3
Lanzhou 3
Naples 3
Padova 3
San Genesio Ed Uniti 3
Seregno 3
St Petersburg 3
Turin 3
Venezia 3
Atlanta 2
Auburn Hills 2
Baghdad 2
Bari 2
Barletta 2
Biassono 2
Bientina 2
Borås 2
Buk-gu 2
Cape Town 2
Chicago 2
Daejeon 2
Desio 2
Dong Ket 2
Eden Prairie 2
Esslingen am Neckar 2
Fairfax 2
Florence 2
Francavilla Al Mare 2
Gunzenhausen 2
Hirakata 2
Totale 5.109
Salva come PNG Salva come JPEG
Nome #
Identificazione di microRNA circolanti specificatamente sovra espressi in corso di infarto miocardico acuto. 217
Cellule staminali mesenchimali fetali isolate da placenta esercitano effetti paracrini cardioprotettivi. 132
Allogeneic Lethally Irradiated Cord Blood Mononuclear Cells in No-Option Critical Limb Ischemia: A “Box of Rain” 94
Studio pilota sull'impiego di cellule CD133+ immunoselezionate per il trattamento di vasculopatie periferiche. 83
Rat experimental model of myocardial ischemia/reperfusion injury: an ethical approach to set up the analgesic management of acute post-surgical pain 80
Human fetal mesenchymal stem cells protect cardiac myocytes against hypoxia/reoxygenation injury 79
Concomitant overexpression of IGF1 and BMP2 in mesenchymal stem cells mediates cytoprotection through both autocrine and paracrine activation of Akt, Erk1/2 and SMAD1/5/8 pathways. 76
Conditioned medium from human amniotic mesenchymal stromal cells limits infarct size and enhances angiogenesis 75
Identificazione di fattori paracrini e cardioprotettivi mediante analisi combinata del trascrittoma e del proteoma di cellule staminali mesenchimali fetali. 74
Novel experimental protocol to study area at risk, infarct size, immunohistochemistry and tissue protein content on the same rodent heart. 73
Enhancing stem cell therapy efficacy through genetic modification 71
Gene and cell-based therapies for heart disease 70
Impiego di cellule staminali mesenchimali in cardiologia. 70
Improved transduction efficiency of human amniotic mesenchymal stem cells using optimized lentiviral vectors 70
The cardioprotective paracrine effects exerted by human mesenchymal stem cells are negatively influenced by donor age 69
The cardioprotective paracrine effects exerted by human mesenchymal stem cells are negatively influenced by donor age 69
Identification of cardioprotective factors produced by fetal mesenchymal stem cells through a combined transcriptomic and proteomic approach. 69
Cord blood derived endothelial progenitor cells: a superior buiding company in angiogenesis market. 69
Adult stem cell-based therapy for the heart 68
Mesenchymal stem cell therapy for heart disease. 68
Correction to: Cardiac involvement at presentation in patients hospitalized with COVID-19 and their outcome in a tertiary referral hospital in Northern Italy (Internal and Emergency Medicine, (2020), 15, 8, (1457-1465), 10.1007/s11739-020-02493-y) 68
Soluble factors released by human mesenchymal stem cells of fetal origin lead to cardiomyocyte protection through the inhibition of pro-apoptotic signaling 67
Donor Age Negatively Influences Cytoprotective but Not Proangiogenic Paracrine Properties of Human Mesenchymal Stem Cells. 66
Cord blood derived endothelial progenitor cells: time dependent in vitro generation capacity. 65
Overexpression of growth factors to improve cardiac differentiation of human mesenchymal stem cells derived from the amniotic membrane 64
L'età influenza negativamente gli effetti paracrini caridoprotettivi mediati da cellule staminali mesenchimali. 63
Paracrine mechanisms of mesenchymal stem cells in tissue repair 63
Combined transcriptomic and proteomic approach identifies several putative paracrine factors of fetal mesenchymal stem cells. 62
Testing the paracrine properties of human mesenchymal stem cells using conditioned medium 62
Synthetic extracellular matrix mimic hydrogel improves efficacy of mesenchymal stromal cell therapy for ischemic cardiomyopathy. 61
IRES-based lentivirus co-espressing TGFbeta1 and FGF2 improves cell survival and angiogenesis in bone marrow-derived mesenchymal stem cells. 60
Strategies for reducing door to balloon time in patients with acute myocardial infarction undergoing primary angioplasty: the Pavia experience 60
Mesenchymal stem cell therapy for heart disease. 59
Amyloidogenic light chains induce human cardiac fibroblast toxicity through alteration of mitochondrial functionality 59
Protocols for in vitro differentiation of human mesenchymal stem cells into osteogenic, chondrogenic and adipogenic lineages 59
Combination of miRNA499 and miRNA133 exerts a synergic effect on cardiac differentiation 59
Enhancing the cardiomyogenic potential of human mesenchymal stem cells by modulation of miR expression. 58
PBMC microRNA-155 is up-regulated in chronic hemodialysis patients. 57
MicroRNA133 and microRNA499 exert synergistic effect on cardiac differentiation 56
Cardiac involvement at presentation in patients hospitalized with COVID-19 and their outcome in a tertiary referral hospital in Northern Italy 56
Cytokine-induced mobilization of circulating endothelial progenitor cells enhances repair of injured arteries 55
Bone marrow-derived mesenchymal stem cells: isolation, expansion, characterization, viral transduction and conditioned media production 55
Comparison of Outcomes of Staged Complete Revascularization Versus Culprit Lesion–Only Revascularization for ST-Elevation Myocardial Infarction and Multivessel Coronary Artery Disease 55
La contemporanea overespressione di miRNA499 e miRNA133 induce il differenziamento in senso cardiomiocitario di cellule staminali pluripotenti. 54
From patient-specific induced pluripotent stem cells to clinical translation in long QT syndrome Type 2 54
Generation of the human induced pluripotent stem cell (hiPSC) line PSMi002-A from a patient affected by the Jervell and Lange-Nielsen syndrome and carrier of two compound heterozygous mutations on the KCNQ1 gene 54
Vascular remodeling in health and disease 53
Evidence supporting paracrine hypothesis for Akt-modified mesenchymal stem cell mediated cardiac repair and functional improvement 53
Endothelium-targeted gene and cell based therapy for cardiovascular disease 53
The KCNH2-IVS9-28A/G mutation causes aberrant isoform expression and hERG trafficking defect in cardiomyocytes derived from patients affected by Long QT Syndrome type 2 53
Pentraxin-3 and galectin-1 are key mediators of the cardioprotective paracrine effects exerted by fetal mesenchymal stem cells isolated from human placenta 53
Generation of the human induced pluripotent stem cell (hiPSC) line PSMi007-A from a Long QT Syndrome type 1 patient carrier of two common variants in the NOS1AP gene 53
Prognostic Impact of in-Hospital-Bleeding in Patients With ST-Elevation Myocardial Infarction Treated by Primary Percutaneous Coronary Intervention 52
Smoker's paradox in ST-elevation myocardial infarction: Role of inflammation and platelets 52
Calcineurin Inhibitor-Based Immunosuppression and COVID-19: Results from a Multidisciplinary Cohort of Patients in Northern Italy 52
Angiography- versus physiology-guided complete revascularization in patients with STEMI and multivessel disease: who's the better gatekeeper in this setting? 52
Human fetal mesenchymal stem cells exert more powerful cytoprotective paracrine effects than bone marrow-derived mesenchymal stem cells 51
microRNA and Cardiac Regeneration 51
Novel IRES-based lentivirus co-expressing IGF1 and BMP2 enhances both cardiomyogenesis and cytoprotection of bone marrow-derived mesenchymal stem cells 51
Identification of a targeted and testable antiarrhythmic therapy for long-QT syndrome type 2 using a patient-specific cellular model 51
Injected adult bone marrow-derived stem cells fuse with cardiomyocytes in the infarcted heart 50
Long-term clinical outcome after directional coronary atherectomy followed by stem implantation 50
Generation of the human induced pluripotent stem cell (hiPSC) line PSMi003-A from a patient affected by an autosomal recessive form of Long QT Syndrome type 1 50
Paracrine mechanisms of stem cell reparative and regenerative actions in the heart 50
Angiotensin-converting enzyme insertion/deletion polymorphism and risk of restenosis after directional coronary atherectomy followed by stent implantation 49
Insertion/deletion polymorphism of the Angiotensin I-Converting Enzyme gene and risk of restenosis after directional coronary atherectomy followed by stent implantation 49
Direct oral Xa inhibitors versus warfarin in patients with cancer and atrial fibrillation: a meta-analysis 49
Stem cell therapy for heart repair: the paracrine paradigm. 48
The unfavourable inflammatory response in elderly patients after myocardial infarction: should we talk of 'dysflammaging'? 48
Soluble factors released by human mesenchymal stem cells of fetal origin lead to cardiomyocyte protection through the inhibition of pro-apoptotic signaling 47
Elucidating arrhythmogenic mechanisms of long-QT syndrome CALM1-F142L mutation in patient-specific induced pluripotent stem cell-derived cardiomyocytes 47
Paracrine action accounts for marked protection of ischemic heart by Akt modified mesenchymal stem cells. 47
Generation of the human induced pluripotent stem cell (hiPSC) line PSMi004-A from a carrier of the KCNQ1-R594Q mutation 47
Cell Therapy for Heart Regeneration: Learning from the Past to Build a Brighter Future 47
Favorable effect of glycoprotein IIbIIIa inhibitors among STEMI patients treated with primary PCI and incomplete ST resolution 46
Generation of the human induced pluripotent stem cell (hiPSC) line PSMi005-A from a patient carrying the KCNQ1-R190W mutation 46
Risk factors for primary ventricular fibrillation during a first myocardial infarction: Clinical findings from PREDESTINATION (PRimary vEntricular fibrillation and suDden dEath during firST myocardIal iNfArcTION) 46
Mesenchymal stem cells overexpressing Akt exhibit enhanced glucose transport and resist hypoxia induced apoptosis 45
Donor age negatively influences the cytoprotective paracrine effects exerted by human mesenchymal stem cells 45
Proteotoxicity in cardiac amyloidosis: Amyloidogenic light chains affect the levels of intracellular proteins in human heart cells 45
Genetic therapies for cardiovascular diseases: where we are and where we are going 45
Pulmonary embolism in patients with COVID-19: characteristics and outcomes in the Cardio-COVID Italy multicenter study 45
Secreted frizzled related protein 2 (Sfrp2) is the key Akt-mesenchymal stem cell-released paracrine factor mediating myocardial survival and repair 44
Liver X receptors a and b are in vivo pathophysiological regulators of renin 44
Genotype-Phenotype Correlation in Induced Pluripotent Stem Cell (iPSC) Derived Cardiomyocytes Carrying Calmodulin Mutations 44
Cord blood-derived endothelial progenitor cells: a superior building company in the angiogenesis market: P599 44
Generation of two human induced pluripotent stem cell (hiPSC) lines from a long QT syndrome South African founder population 43
Transplantation of bone marrow-derived cells expressing Akt into infarcted murine heart produces dramatic improvement in cardiac function despite infrequent cellular fusion. 43
Optimized lentiviral transduction of human amniotic mesenchymal stromal cells 41
Endothelium targeted gene and cell based therapies for vascular diseases 40
Insertion/deletion polymorphism of the Angiotensin I-Converting Enzyme gene and risk of restenosis after directional coronary atherectomy followed by stent implantation 40
Early beneficial effects of bone marrow derived mesenchymal stem cells overexpressing Akt on cardiac metabolism after myocardial infarction 39
Machine learning for prediction of in-hospital mortality in coronavirus disease 2019 patients: results from an Italian multicenter study 38
Identification of upregulated microRNAs in the plasma of patients with acute myocardial infarction 38
Generation of the human induced pluripotent stem cell (hiPSC) line PSMi006-A from a patient affected by an autosomal recessive form of long QT syndrome type 1 38
Neutrophil to platelet ratio: a novel prognostic biomarker in ST-elevation myocardial infarction patients undergoing primary percutaneous coronary intervention 38
Overexpression of Akt in mesenchymal stem cells improves ATP production under hypoxia by increasing glucose uptake and mitochondrial enzymes activity: a possible explanation for increased resistence to apoptosis. 37
Mesenchymal stem cells overesxpressing Akt prevent cardiac metabolic remodelling after infarction. 37
Long QT Syndrome modelling with cardiomyocytes derived from human-induced pluripotent stem cells 37
Tuning tissue ingrowth into pro-angiogenic hydrogels via dual modality degradation 37
Totale 5.720
Salva come PNG Salva come JPEG
Categoria #
all - tutte 34.254
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 34.254
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020301 0 0 0 0 0 0 8 73 26 122 65 7
2020/2021582 65 43 17 42 42 78 4 90 41 70 70 20
2021/2022588 6 9 26 7 15 23 9 46 45 16 92 294
2022/20232.151 225 155 37 131 207 211 5 116 950 22 55 37
2023/2024953 99 177 33 62 84 270 33 52 6 40 56 41
2024/2025563 63 173 37 55 79 148 8 0 0 0 0 0
Totale 7.181